Poniard Pharmaceuticals Inc (PARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2011 | 06-2011 | 03-2011 | 12-2010 | 09-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,870 | -7,100 | -3,240 | -30,050 | -24,880 |
| Depreciation Amortization | 960 | 650 | 330 | 2,840 | 2,190 |
| Other Working Capital | 1,930 | 850 | -130 | -6,930 | -4,350 |
| Other Operating Activity | 2,570 | 1,900 | 1,020 | 9,870 | 7,810 |
| Operating Cash Flow | $-5,410 | $-3,700 | $-2,020 | $-24,270 | $-19,230 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9 | -9 | -7 | 50 | 50 |
| Other Investing Activity | 3,029 | 3,029 | 3,027 | 23,970 | 14,760 |
| Investing Cash Flow | $3,020 | $3,020 | $3,020 | $24,020 | $14,810 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -90 | -90 | 0 | -190 | -90 |
| Other Financing Activity | 3,170 | 3,170 | 3,180 | -14,210 | -410 |
| Financing Cash Flow | $3,080 | $3,080 | $3,180 | $-14,400 | $-500 |
| Beginning Cash Position | 1,280 | 1,280 | 1,280 | 15,930 | 15,930 |
| End Cash Position | 1,980 | 3,690 | 5,470 | 1,280 | 11,010 |
| Net Cash Flow | $700 | $2,400 | $4,180 | $-14,650 | $-4,920 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,410 | -3,700 | -2,020 | -24,270 | -19,230 |
| Free Cash Flow | -5,410 | -3,700 | -2,020 | -24,270 | -19,230 |